Establishment and characterization of a novel nasopharyngeal carcinoma cell line (SUNE2) from a Cantonese patient

被引:14
作者
Dong, Ju-Qin [1 ,2 ]
Li, Man-Zhi [1 ,2 ]
Liu, Zhi-Gang [1 ,3 ]
Zhong, Qian [1 ,2 ]
Xiong, Dan [1 ,2 ]
Xu, Li-Hua [1 ,2 ]
Du, Yong [1 ,2 ]
Xia, Yun-Fei [1 ,3 ]
Zeng, Mu-Sheng [1 ,2 ]
机构
[1] State Key Lab Oncol South China, Guangzhou 510060, Guangdong, Peoples R China
[2] Sun Yat Sen Univ, Ctr Canc, Dept Expt Res, Guangzhou 510060, Guangdong, Peoples R China
[3] Sun Yat Sen Univ, Ctr Canc, Dept Radiat Therapy, Guangzhou 510060, Guangdong, Peoples R China
基金
中国国家自然科学基金;
关键词
Nasopharyngeal carcinoma; Epstein-Barr virus; SUNE2 cell line;
D O I
10.5732/cjc.011.10317
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The undifferentiated form of nasopharyngeal carcinoma (NPC) is the most common malignant head and neck cancer in South China, especially in Cantonese populations. However, few NPC cell lines have been established from the patients in this region. In this study, we established a new NPC cell line, termed SUNE2, from a Cantonese patient with undifferentiated NPC. This cell line had extremely low concentrations of Epstein-Barr virus (EBV) DNA in long-term culture and expressed low levels of latent membrane protein 1 (LMP1), latent membrane protein 2A (LMP2A), BamH1-A right frame 1 (BARF1), EBV-encoded RNA-1 (EBER1), and EBV-encoded RNA-2 (EBER2) in early passages. SUNE2 cells also showed much stronger transforming ability than 5-8F cells in colony formation assays and anchorage-independent growth assays in soft agar, and they only need 2 weeks to form tumors in nude mice. In summary, the SUNE2 cell line is a new in vitro model that can be used for further research on the mechanisms underlying the occurrence and development of NPC.
引用
收藏
页码:36 / 44
页数:9
相关论文
共 22 条
[11]  
GAZZOLO L, 1972, JNCI-J NATL CANCER I, V48, P73
[12]   2 EPITHELIAL TUMOR-CELL LINES (HNE-1 AND HONE-1) LATENTLY INFECTED WITH EPSTEIN-BARR VIRUS THAT WERE DERIVED FROM NASOPHARYNGEAL CARCINOMAS [J].
GLASER, R ;
ZHANG, HY ;
YAO, K ;
ZHU, HC ;
WANG, FX ;
LI, GY ;
WEN, DS ;
LI, YP .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (23) :9524-9528
[13]  
Gullo C, 2008, ANN ACAD MED SINGAP, V37, P769
[14]   Characterization of a new EBV-associated nasopharyngeal carcinoma cell line [J].
Hui, ABY ;
Cheung, ST ;
Fong, Y ;
Lo, KW ;
Huang, DP .
CANCER GENETICS AND CYTOGENETICS, 1998, 101 (02) :83-88
[15]   EPSTEIN-BARR-VIRUS - INCREASING EVIDENCE OF A LINK TO CARCINOMA [J].
KIEFF, E .
NEW ENGLAND JOURNAL OF MEDICINE, 1995, 333 (11) :724-726
[16]   Focus on nasopharyngeal carcinoma [J].
Lo, KW ;
To, KF ;
Huang, DP .
CANCER CELL, 2004, 5 (05) :423-428
[17]   Epstein-Barr virus in the pathogenesis of NPC [J].
Raab-Traub, N .
SEMINARS IN CANCER BIOLOGY, 2002, 12 (06) :431-441
[18]   Noninvasive diagnosis of nasopharyngeal carcinoma: nasopharyngeal brushings reveal high Epstein-Barr virus DNA load and carcinoma-specific viral BARF1 mRNA [J].
Stevens, Servi J. C. ;
Verkuijlen, Sandra A. W. M. ;
Hariwiyanto, Bambang ;
Harijadi ;
Paramita, Dewi K. ;
Fachiroh, Jajah ;
Adham, Marlinda ;
Tan, I. Bing ;
Haryana, Sophia M. ;
Middeldorp, Jaap M. .
INTERNATIONAL JOURNAL OF CANCER, 2006, 119 (03) :608-614
[19]   Detection of Epstein-Barr virus DNA in well and poorly differentiated nasopharyngeal carcinoma cell lines [J].
Teng, ZP ;
Ooka, T ;
Huang, DP ;
Zeng, Y .
VIRUS GENES, 1996, 13 (01) :53-60
[20]   Nasopharynx: clinical, pathologic, and radiologic assessment [J].
Weber, AL ;
Al Arayedh, S ;
Rashid, A .
NEUROIMAGING CLINICS OF NORTH AMERICA, 2003, 13 (03) :465-+